Roelofsen T - Search Results

1

Histone modification patterns associated with the human X chromosome.

Brinkman AB, Roelofsen T, Pennings SW, Martens JH, Jenuwein T, Stunnenberg HG. Brinkman AB, et al. Among authors: roelofsen t. EMBO Rep. 2006 Jun;7(6):628-34. doi: 10.1038/sj.embor.7400686. Epub 2006 Apr 28. EMBO Rep. 2006. PMID: 16648823 Free PMC article.

2

Clinical management of uterine papillary serous carcinoma.

Roelofsen T, van Ham MA, de Hullu JA, Massuger LF. Roelofsen T, et al. Expert Rev Anticancer Ther. 2011 Jan;11(1):71-81. doi: 10.1586/era.10.199. Expert Rev Anticancer Ther. 2011. PMID: 21166512 Review.

3

Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice.

Nierkens S, den Brok MH, Roelofsen T, Wagenaars JA, Figdor CG, Ruers TJ, Adema GJ. Nierkens S, et al. Among authors: roelofsen t. PLoS One. 2009 Dec 18;4(12):e8368. doi: 10.1371/journal.pone.0008368. PLoS One. 2009. PMID: 20020049 Free PMC article.

4

Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts.

Roelofsen T, Akkers R, Beumer W, Apotheker M, Steeghs I, van de Ven J, Gelderblom C, Garritsen A, Dechering K. Roelofsen T, et al. J Cell Biochem. 2008 Nov 1;105(4):1128-38. doi: 10.1002/jcb.21915. J Cell Biochem. 2008. PMID: 18819098

5

Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?

Roelofsen T, van Kempen LC, van der Laak JA, van Ham MA, Bulten J, Massuger LF. Roelofsen T, et al. Int J Gynecol Cancer. 2012 Mar;22(3):457-64. doi: 10.1097/IGC.0b013e3182434a81. Int J Gynecol Cancer. 2012. PMID: 22249577

6

Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients.

Roelofsen T, Mingels M, Hendriks JC, Samlal RA, Snijders MP, Aalders AL, Bulten J, van Ham MA, Massuger LF. Roelofsen T, et al. Int J Biol Markers. 2012 Oct 8;27(3):e263-71. doi: 10.5301/JBM.2012.9346. Int J Biol Markers. 2012. PMID: 22865295 Free article.

7

Pure compared with mixed serous endometrial carcinoma: two different entities?

Roelofsen T, van Ham MA, Wiersma van Tilburg JM, Zomer SF, Bol M, Massuger LF, Bulten J. Roelofsen T, et al. Obstet Gynecol. 2012 Dec;120(6):1371-81. doi: 10.1097/aog.0b013e318273732e. Obstet Gynecol. 2012. PMID: 23168762

8

Cervical cytology in serous and endometrioid endometrial cancer.

Roelofsen T, Geels YP, Pijnenborg JM, van Ham MA, Zomer SF, van Tilburg JM, Snijders MP, Siebers AG, Bulten J, Massuger LF. Roelofsen T, et al. Int J Gynecol Pathol. 2013 Jul;32(4):390-8. doi: 10.1097/PGP.0b013e31826a62bb. Int J Gynecol Pathol. 2013. PMID: 23722512

9

The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis.

Massuger L, Roelofsen T, Ham Mv, Bulten J. Massuger L, et al. Among authors: roelofsen t. Med Hypotheses. 2010 May;74(5):859-61. doi: 10.1016/j.mehy.2009.11.029. Epub 2009 Dec 21. Med Hypotheses. 2010. PMID: 20022435

10

Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls.

Mingels MJ, Roelofsen T, van der Laak JA, de Hullu JA, van Ham MA, Massuger LF, Bulten J, Bol M. Mingels MJ, et al. Among authors: roelofsen t. Gynecol Oncol. 2012 Oct;127(1):88-93. doi: 10.1016/j.ygyno.2012.06.015. Epub 2012 Jun 16. Gynecol Oncol. 2012. PMID: 22710074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page